Home / Companies / Monopar Therapeutics Inc. / 22 Jun 2026
Monopar Therapeutics Inc.: meeting of 22 Jun 2026
Votes reported on Form N-PX, item by item
140 Form N-PX filers reported votes at the Monopar Therapeutics Inc. meeting of 22 Jun 2026. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
6 nominees; 69.0% of reported votes for; 37 filers withheld from or voted against at least one nominee.
565 vote records from 56 filers. 2 of the 54 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
200 vote records from 139 filers. 56 of the 133 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
95 vote records from 56 filers. 0 of the 54 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
99 vote records from 57 filers. 18 of the 55 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| State Street and SPDR | For | For | For |
| American Century | Split or no vote | Against * | For |
| Invesco | No report | Against * | No report |
| Equitable | For | For | For |
| Charles Schwab | For | For | For |
| Nuveen and TIAA | Abstain or withhold * | For | For |
| ProShares and ProFunds | Split or no vote | Against * | For |
| John Hancock and Manulife | Split or no vote | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | For | For |
| J.P. Morgan | No report | For | No report |
| Goldman Sachs | For | For | For |
| PGIM and Prudential | No report | For | No report |
| Northern Trust and FlexShares | Split or no vote | Against * | Split or no vote |
| SEI | Split or no vote | For | For |
| T. Rowe Price | Split or no vote | Against * | For |
| Lincoln Financial | For | For | For |
| Voya | Split or no vote | For | For |
| Russell Investments | Split or no vote | For | For |
| Nationwide | For | For | For |
| Victory Capital | Split or no vote | Against * | For |
| Brighthouse Funds | Split or no vote | Against | For |
| Guggenheim and Rydex | Split or no vote | Against * | For |
| Columbia Threadneedle | For | Against * | For |
| BNY Mellon | For | Against * | For |
| Principal | Split or no vote | Against * | For |
| Pacific Life funds | For | For | For |
| Global X | Split or no vote | For | For |
| AllianceBernstein | No report | Against * | No report |
| DWS | Split or no vote | Against * | For |
| Janus Henderson | No report | For | No report |
| Neuberger Berman | Split or no vote | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Monopar Therapeutics Inc. meeting?
140 Form N-PX filers reported votes at the meeting of 22 Jun 2026. On say-on-pay, 56 of 133 voted against management (42.1%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Monopar Therapeutics Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Monopar Therapeutics Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Monopar Therapeutics Inc. with a meeting date within three days of 22 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.